Nurix Therapeutics, Inc. NRIX Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance?
- Nurix Therapeutics, Inc. (NRIX) reported common stock, capital shares reserved for future issuance of $31.15M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance increased by 12.3% year-over-year, from $27.74M to $31.15M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s common stock, capital shares reserved for future issuance has grown at a 13.9% compound annual growth rate (CAGR), from $18.02M to $26.65M.